Cargando…
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
SIMPLE SUMMARY: Recently immunotherapy has been approved in first line for patients with MPM. However, the benefit of immunotherapy in MPM is modest, and recognizing the immune landscape of this tumor could guide the optimal therapeutic strategy. In some tumors dynamic changes of TILs has been repor...
Autores principales: | Cedres, Susana, Serna, Garazi, Gonzalez-Medina, Alberto, Valdivia, Augusto, Assaf-Pastrana, Juan David, Iranzo, Patricia, Callejo, Ana, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Priano, Ilaria, Fasani, Roberta, Guardia, Xavier, Gonzalo, Javier, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Navarro, Victor, Dienstmann, Rodrigo, Vivancos, Ana, Nuciforo, Paolo, Felip, Enriqueta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377125/ https://www.ncbi.nlm.nih.gov/pubmed/37509274 http://dx.doi.org/10.3390/cancers15143611 |
Ejemplares similares
-
MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021) -
Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
por: Carbonell, Caterina, et al.
Publicado: (2023) -
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
por: Frigola, Joan, et al.
Publicado: (2022) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
por: Cedres, Susana, et al.
Publicado: (2021) -
Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
por: Cedrés, Susana, et al.
Publicado: (2015)